Cooper and Inspira Cardiac Care First in the Region to Implant New Heart Valve Replacement for Triscuspid Regurgitation
July 30, 2024
July 30, 2024
CAMDEN, New Jersey, July 30 -- Cooper University Health Care issued the following news release:
A team of cardiologists at Cooper and Inspira Cardiac Care recently became the first in the region to implant the EVOQUE tricuspid valve replacement system, the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation. The procedure took place at Cooper University Hospital in Camden.
Tricuspid regurgi . . .
A team of cardiologists at Cooper and Inspira Cardiac Care recently became the first in the region to implant the EVOQUE tricuspid valve replacement system, the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation. The procedure took place at Cooper University Hospital in Camden.
Tricuspid regurgi . . .